...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Free
Message: My take from the webcast,

Except for a very marginal statistical miss on the primary end point,

The Forest Plot for all of the secondary end points will show Apabetalone outperforming placebo!

A major point of significant interest would be the treatment performance vs each of the statins (Crestor vs Lipitor), which might be a big difference maker as well!!!!

Looking forward to November 18 CC & then the December CTAD data!!!

 

Share
New Message
Please login to post a reply